DRUG COMPANY SUES TO PREVENT SALE OF GENERIC WEIGHT-GAIN PRODUCT Savient Pharms. v. Sandoz | Secondary Sources | Westlaw

DRUG COMPANY SUES TO PREVENT SALE OF GENERIC WEIGHT-GAIN PRODUCT Savient Pharms. v. Sandoz | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, DRUG COMPANY SUES TO PREVENT SALE OF GENERIC WEIGHT-GAIN PRODUCT Savient Pharms. v. Sandoz, Secondary Sources
Skip Page Header

DRUG COMPANY SUES TO PREVENT SALE OF GENERIC WEIGHT-GAIN PRODUCT Savient Pharms. v. Sandoz

13 No. 19 ANIPLR 4Andrews Intellectual Property Litigation Reporter (Approx. 3 pages)

DRUG COMPANY SUES TO PREVENT SALE OF GENERIC WEIGHT-GAIN PRODUCT Savient Pharms. v. Sandoz

13 No. 19 ANIPLR 4Andrews Intellectual Property Litigation Reporter (Approx. 3 pages)

13 No. 19 Andrews Intell. Prop. Litig. Rep. 4
Andrews Intellectual Property Litigation Reporter
*1 January 3, 2007
Patent Infringement
Copyright © 2007 Thomson/West .

DRUG COMPANY SUES TO PREVENT SALE OF GENERIC WEIGHT-GAIN PRODUCT

Savient Pharms. v. Sandoz

Briefs and Other Related Documents
Savient Pharmaceuticals Inc. is suing two drug companies for allegedly infringing five of its patents related to methods for using Savient's oral anabolic agent Oxandrin.
Savient Pharmaceuticals Inc. v. Sandoz Inc. et al., No. 06-5782, complaint filed...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.